The National Institute of Arthritis, Diabetes, Digestive and Kidney Disease, or NIADDK (formerly the National Institute of Diabetes, Digestive and Kidney Disease, or NIDDK) developed criteria for interstitial cystitis that could be used for clinical trials.
